Key facts
- Notable investors include Hangzhou Puhua Tianji Investment, Silicon Valley Real Stone Asset Management, ZJKF Capital Management, Zhejiang Dajing Development Investment.
- Status: Privately Held (backing).
- ·The complete investor list — 4 names
- ·Watchlist + deal alerts for Zhifeng Pharmaceutical
- ·The full record, as it builds
Funding rounds
No funding rounds for Zhifeng Pharmaceutical are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Zhifeng Pharmaceutical
Manufacturer of medical technology and biopharmaceutical research intended to advance clinical development and healthcare innovation. The company offers expertise in experimental medicine, biochemistry research, and medical device distribution, enabling healthcare institutions and research organizations to access advanced therapeutic technologies and improved patient care.
- Sector
- Healthcare
- HQ
- Jinhua, China
- Founded
- 2025
- Ownership
- Privately Held (backing)
Zhifeng Pharmaceutical doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Zhifeng Pharmaceutical shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Zhifeng Pharmaceutical in its N-PORT filings yet. We sweep new filings monthly.